TRACON Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and through our license to Santen …